HemoChat is an evidence-based AI medical search tool covering all major clinical domains, powered by 46,298 SNOMED-CT concepts, clinical guidelines, and live PubMed literature.

What medical domains does HemoChat cover?

HemoChat covers all major medical domains including cardiology, oncology, neurology, hematology, pulmonology, endocrinology, gastroenterology, psychiatry, nephrology, rheumatology, musculoskeletal, and more — with 46,298 SNOMED-CT concepts.

Is HemoChat a replacement for clinical judgment?

No. HemoChat is for clinical reference only and is not a substitute for professional medical judgment. Always consult qualified healthcare professionals for medical decisions.

What AI technology does HemoChat use?

HemoChat uses a hybrid GraphRAG + VectorRAG pipeline combining Neo4j knowledge graphs with FAISS vector search and an LLM for answer generation.

Bell's palsy — Clinical Guidelines

Overview

Bell's palsy is the most common acute mononeuropathy characterized by unilateral facial nerve paresis or paralysis of unknown cause, leading to facial muscle weakness or paralysis 3 5.

Diagnosis

Clinical Presentation: Rapid onset of unilateral facial weakness or paralysis 5.

Neurological Examination: Thorough assessment to rule out other causes of facial nerve dysfunction 2.

Imaging: MRI or CT scans may be considered if there is suspicion of other pathologies (e.g., tumor, stroke) 5.

Electrophysiological Tests: Electromyography (EMG) and nerve conduction studies can differentiate Bell's palsy from other conditions but are not routinely necessary 5.

Management

First-Line Treatment: Corticosteroids (e.g., prednisone 1 mg/kg/day for 7-10 days) to reduce inflammation and improve recovery 3 5.

Adjunctive Therapy: Antiviral medications (e.g., acyclovir) may be considered, especially in the early stages, though evidence is mixed 3 5.

Supportive Care: Eye protection (e.g., artificial tears, eye patches) to prevent corneal dryness and ulceration 5.

Physical Therapy: Facial exercises may aid recovery but are not universally recommended 5.

Special Populations

Pregnancy: Corticosteroids are generally considered safe during pregnancy; consult guidelines for specific dosing 5.

Pediatrics: Management principles are similar to adults, but dosing adjustments may be necessary; close monitoring is advised 5.

Elderly: Similar treatment approaches apply, with careful consideration of comorbidities and medication interactions 5.

Comorbidities: Patients with concurrent neurological conditions require thorough evaluation to exclude other causes; management should be individualized 5.

Key Recommendations

Initiate corticosteroid therapy within 72 hours of symptom onset to improve recovery outcomes (Evidence: Strong) 3 5.

Consider antiviral therapy in conjunction with corticosteroids, particularly in the early phase, though evidence is moderate (Evidence: Moderate) 3 5.

Provide protective eye care to prevent complications such as corneal ulceration (Evidence: Expert opinion) 5.

Tailor management in special populations like pregnancy and the elderly, considering individual risks and benefits (Evidence: Expert opinion) 5.

References

1 Taufique Z, Timen M, Swartz JL, Friedmann DR. Adherence to Subspecialty Guidelines in the Emergency Department. The Laryngoscope 2021. link 2 Fieux M, Franco-Vidal V, Devic P, Bricaire F, Charpiot A, Darrouzet V et al.. French Society of ENT (SFORL) guidelines. Management of acute Bell's palsy. European annals of otorhinolaryngology, head and neck diseases 2020. link 3 Schwartz SR, Jones SL, Getchius TS, Gronseth GS. Reconciling the clinical practice guidelines on Bell's palsy from the AAO-HNSF and the AAN. Otolaryngology--head and neck surgery : official journal of American Academy of Otolaryngology-Head and Neck Surgery 2014. link 4 Schwartz SR, Jones SL, Getchius TS, Gronseth GS. Reconciling the clinical practice guidelines on Bell's palsy from the AAO-HNSF and the AAN. Neurology 2014. link 5 Baugh RF, Basura GJ, Ishii LE, Schwartz SR, Drumheller CM, Burkholder R et al.. Clinical practice guideline: Bell's palsy. Otolaryngology--head and neck surgery : official journal of American Academy of Otolaryngology-Head and Neck Surgery 2013. link 6 Grzybowski A, Kaufman MH. Sir Charles Bell (1774-1842): contributions to neuro-ophthalmology. Acta ophthalmologica Scandinavica 2007. link 7 Zhou W, Pool V, DeStefano F, Iskander JK, Haber P, Chen RT. A potential signal of Bell's palsy after parenteral inactivated influenza vaccines: reports to the Vaccine Adverse Event Reporting System (VAERS)--United States, 1991-2001. Pharmacoepidemiology and drug safety 2004. link 8 Apostolides C, Carr MM. Assessment and management of idiopathic facial (Bell's) palsy: comparison of Nova Scotia family physicians and otolaryngologists. The Journal of otolaryngology 2000. link 9 Erde EL, Eden AR. Ethics and the care of persons with Bell's palsy. Social science & medicine (1982) 1991. link90291-j) 10 Cartwright RA, Boddy J, Barnard D, Bernard S, Bird CC, Roberts BE et al.. Association between Bell's palsy and lymphoid malignancies. Leukemia research 1985. link90019-0) 11 Fisch U, Felix H. On the pathogenesis of Bell's palsy. Acta oto-laryngologica 1983. link 12 Rosenberg S, Goldfarb M. Management of paralytic ectropion. Annals of ophthalmology 1981. link

Bell's palsy